JSM2024
Back to the program
Contributed Papers

Statistical Considerations for Time-to-Event Endpoints

Tue, Aug 6, 2:00 PM - 3:50 PM
Duncan RotichChair
Biopharmaceutical Section

6 Presentations

Bayesian Clinical Trial Design with Time-to-Event Endpoints in the Presence of Semi-Competing Risks
2:05 PM - 2:20 PM
Sasha Kravets (University of Illinois Chicago)
Co-authors: Sanjib Basu (University of Illinois At Chicago)
Computing Sample Size and Power for the Inverse Log-Rank Test
2:20 PM - 2:35 PM
Jimmy Efird (Boston VA Cooperative Studies Program Coordinating Center)
Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions
2:35 PM - 2:50 PM
Hong Zhang (Pfizer Inc.)
Co-authors: Jie Pu (Pfizer), Shibing Deng (Pfizer), Satrajit Roychoudhury (Pfizer), Haitao Chu (Pfizer), Douglas Robinson (Pfizer)
Generalized Conditional Power with Time-to-Event Co-Primary Endpoint
2:50 PM - 3:05 PM
Zejiang Yang (Syneos Health)
Parametric survival analyses for lifetime survival prediction
3:05 PM - 3:20 PM
Shu-Ching Chang (The Society of Thoracic Surgeons)
Co-authors: Gary Grunkemeier (M D R C)
Statistical Considerations and Challenges with Time-to-Event Analyses for Composite Endpoints
3:20 PM - 3:35 PM
Kaiyi Chen
Co-authors: Yuxin Zhu (Johns Hopkins University), Yu Du (Eli Lilly and Company)
↑